Davis Heart & Lung Research Institute

Columbus, Ohio 43210-1252

0 studies enrolling now · 4 studies all time

What they study most

Atrial Fibrillation, Healthy Individuals, Heart Failure, Pulmonary Arterial Hypertension

Studies at this site

• Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure — Completed
• Gene Polymorphism Study of Normal Individual Inflammasome Genes — Withdrawn before enrolling